STOCK TITAN

AORT insider Form 144 lists 2,960-share NYSE sale plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice of proposed sale: A shareholder filed to sell up to 2,960 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $132,071.94. The filing lists an approximate sale date of 11/11/2025 on the NYSE.

The shares were acquired on 11/07/2025 via restricted stock vesting from the issuer, in an amount of 2,960 shares, treated as compensation. Shares outstanding were 47,374,939 at the time referenced in the form; this is a baseline figure, not the amount being sold.

The person for whose account the securities are to be sold reported prior sales in the past three months: 23,356 shares on 08/12/2025 for gross proceeds of $1,004,605.97, and 10,000 shares on 08/25/2025 for gross proceeds of $443,700.00.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does AORT’s Form 144 filing disclose?

It discloses a planned sale of up to 2,960 common shares with an aggregate market value of $132,071.94, to be sold on the NYSE.

When is the proposed sale date in the AORT Form 144?

The filing lists an approximate sale date of 11/11/2025.

How were the shares in the AORT Form 144 acquired?

They were acquired on 11/07/2025 via restricted stock vesting from the issuer, recorded as compensation.

Which broker is named in the AORT Form 144?

The broker is Fidelity Brokerage Services LLC (900 Salem Street, Smithfield, RI 02917).

How many AORT shares were outstanding according to the filing?

The filing lists 47,374,939 shares outstanding.

What prior sales were reported in the past three months?

Reported sales include 23,356 shares on 08/12/2025 for $1,004,605.97 and 10,000 shares on 08/25/2025 for $443,700.00.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

1.82B
43.32M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW